Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2003

View Archived Issues

EPI-4067: multitargeting antisense oligonucleotide for the treatment of allergic disease and asthma

New anticoccidial agents from fungal origin presented by Meiji Seika and Mitsubishi Chemical

Neurocrine Biosciences identifies novel GnRH antagonists

Nociceptin receptor agonists identified by Banyu researchers

Nikken Chemicals presents new antiasthmatic compound with dual mechanism

Novel nicotinic receptor modulators and their use as peripheral analgesics

Pyrazole ERK/Akt kinase inhibitors prepared and tested at Vertex

Merck scientists describe tissue-selective androgen receptor modulators for bone disorders

New androgen receptor modulators and their use in age-related conditions reported by BMS

NSAIDs shown to bind to beta-amyloid senile plaques in vitro

SR-13668 selected by NCI for RAPID program

P57 program progresses at Pfizer

Romark launches Alinia for children in U.S.

Phase II Alista trial begins recruitment

FDA approves expanded label for Betaseron; ABOVE trial explores increased dose and frequency

Phase III decitabine study in MDS completes patient enrollment

Results reported for phase III trial of Affinitak in NSCLC

H3 Pharma licenses SC-1 from OncoMab

Further analysis of DIAMOND study data reported

Phase I IND for AVP-13358 cleared

Dual erbB-2/EGFR tyrosine kinase inhibitor with promising preclinical profile

Toxicity of LE-SN-38 in dogs after repeated i.v. doses

Acute and subchronic toxicity testing conducted on CJC-1131 in rats and dogs

Calmodulin antagonist DY-9760e improves brain edema by inhibiting enhanced BBB permeability

One course of AIC immunotherapy lasts through two allergy seasons according to phase II data

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...